Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15

2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.2 Major Growth Drivers 18
2.3 Market Restraints and Challenges 21
2.4 Emerging Opportunities and Market Trends 24
2.5 Porter’s Fiver Forces Analysis 27

3 Segmentation of Europe Market by Product Type 31
3.1 Market Overview by Product Type 31
3.2 Human Insulin Drugs 33
3.3 Human Insulin Delivery Devices 34

4 Segmentation of Europe Human Insulin Drugs Market by Drug Product 35
4.1 Market Overview by Drug Product 35
4.2 Modern Human Insulin 37
4.2.1 Modern Human Insulin by Type 39
4.2.2 Modern Human Insulin by Brand 42
4.3 Traditional Human Insulin 49
4.3.1 Traditional Human Insulin by Type 51
4.3.2 Traditional Human Insulin by Brand 54

5 Segmentation of Europe Human Insulin Delivery Devices Market by Device Product 57
5.1 Market Overview by Product 57
5.2 Syringes 59
5.3 Pens 60
5.4 Pumps 61
5.5 Other Devices 62

6 Segmentation of Europe Market by Application 63
6.1 Market Overview by Application 63
6.2 Type 1 Diabetes 65
6.3 Type 2 Diabetes 66
6.4 Gestational Diabetes and Prediabetes 67

7 Segmentation of Europe Market by Distribution Channel 68
7.1 Market Overview by Distribution Channel 68
7.2 Hospital Pharmacies 70
7.3 Retail Pharmacies 71
7.4 Online Pharmacies 72

8 European Market 2019-2026 by Country 73
8.1 Overview of European Market 73
8.2 Germany 76
8.3 UK 78
8.4 France 80
8.5 Spain 82
8.6 Italy 84
8.7 Rest of European Market 86

9 Competitive Landscape 88
9.1 Overview of Key Vendors 88
9.2 New Product Launch, Partnership, Investment, and M&A 92
9.3 Company Profiles 94
Astra Zeneca PLC 94
Biocon 96
Eli Lilly 97
Exir 98
Julphar 99
Novo Nordisk AS 100
Pfizer 101
Sanofi Aventis 102
Sedico 103
Wockhardt 104

10 Investing in Europe Market: Risk Assessment and Management 105
10.1 Risk Evaluation of Europe Market 105
10.2 Critical Success Factors (CSFs) 108
Related Reports and Products 111



List of Figures


Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 15
Figure 4. Europe Human Insulin Market, 2019-2026, $ mn 17
Figure 5. Primary Drivers and Impact Factors of Europe Human Insulin Market 18
Figure 6. Primary Restraints and Impact Factors of Europe Human Insulin Market 21
Figure 7. Porter’s Fiver Forces Analysis of Europe Human Insulin Market 27
Figure 8. Breakdown of Europe Human Insulin Market by Product Type, 2019-2026, % of Revenue 31
Figure 9. Contribution to Europe 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%) 32
Figure 10. Europe Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn 33
Figure 11. Europe Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn 34
Figure 12. Breakdown of Europe Human Insulin Drugs Market by Product, 2019-2026, % of Revenue 35
Figure 13. Contribution to Europe Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 36
Figure 14. Europe Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn 37
Figure 15. Europe Modern Human Insulin Market: Long-acting, 2019-2026, $ mn 39
Figure 16. Europe Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn 40
Figure 17. Europe Modern Human Insulin Market: Premixed, 2019-2026, $ mn 41
Figure 18. Europe Modern Human Insulin Market: Lantus, 2019-2026, $ mn 42
Figure 19. Europe Modern Human Insulin Market: Apidra, 2019-2026, $ mn 43
Figure 20. Europe Modern Human Insulin Market: Levemir, 2019-2026, $ mn 44
Figure 21. Europe Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn 45
Figure 22. Europe Modern Human Insulin Market: Novomix, 2019-2026, $ mn 46
Figure 23. Europe Modern Human Insulin Market: Humalog, 2019-2026, $ mn 47
Figure 24. Europe Modern Human Insulin Market: Other Brands, 2019-2026, $ mn 48
Figure 25. Europe Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn 49
Figure 26. Europe Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn 51
Figure 27. Europe Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn 52
Figure 28. Europe Traditional Human Insulin Market: Premixed, 2019-2026, $ mn 53
Figure 29. Europe Traditional Human Insulin Market: Humulin, 2019-2026, $ mn 54
Figure 30. Europe Traditional Human Insulin Market: Insuman, 2019-2026, $ mn 55
Figure 31. Europe Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn 56
Figure 32. Breakdown of Europe Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue 57
Figure 33. Contribution to Europe Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 58
Figure 34. Europe Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn 59
Figure 35. Europe Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn 60
Figure 36. Europe Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn 61
Figure 37. Europe Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn 62
Figure 38. Breakdown of Europe Human Insulin Market by Application, 2019-2026, % of Revenue 63
Figure 39. Contribution to Europe 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 64
Figure 40. Europe Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn 65
Figure 41. Europe Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn 66
Figure 42. Europe Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn 67
Figure 43. Breakdown of Europe Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue 68
Figure 44. Contribution to Europe 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 69
Figure 45. Europe Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn 70
Figure 46. Europe Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn 71
Figure 47. Europe Human Insulin Market: Online Pharmacies, 2019-2026, $ mn 72
Figure 48. Breakdown of European Human Insulin Market by Country, 2019 and 2026, % of Revenue 74
Figure 49. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 75
Figure 50. Human Insulin Market in Germany, 2019-2026, $ mn 76
Figure 51. Human Insulin Market in UK, 2019-2026, $ mn 78
Figure 52. Human Insulin Market in France, 2019-2026, $ mn 80
Figure 53. Human Insulin Market in Spain, 2019-2026, $ mn 82
Figure 54. Human Insulin Market in Italy, 2019-2026, $ mn 84
Figure 55. Human Insulin Market in Rest of Europe, 2019-2026, $ mn 86
Figure 56. Growth Stage of Europe Human Insulin Industry over the Forecast Period 88


List of Tables


Table 1. Snapshot of Europe Human Insulin Market, 2019-2026 16
Table 2. Main Product Trends and Market Opportunities in Europe Human Insulin Market 24
Table 3. Europe Human Insulin Market by Product Type, 2019-2026, $ mn 31
Table 4. Europe Human Insulin Drugs Market by Product, 2019-2026, $ mn 35
Table 5. Europe Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn 38
Table 6. Europe Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn 38
Table 7. Europe Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn 50
Table 8. Europe Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn 50
Table 9. Europe Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn 57
Table 10. Europe Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn 60
Table 11. Europe Human Insulin Market by Application, 2019-2026, $ mn 63
Table 12. Europe Human Insulin Market by Distribution Channel, 2019-2026, $ mn 68
Table 13. Europe Human Insulin Market by Country, 2019-2026, $ mn 75
Table 14. Germany Human Insulin Market by Product Type, 2019-2026, $ mn 77
Table 15. Germany Human Insulin Market by Application, 2019-2026, $ mn 77
Table 16. Germany Human Insulin Market by Distribution Channel, 2019-2026, $ mn 77
Table 17. UK Human Insulin Market by Product Type, 2019-2026, $ mn 79
Table 18. UK Human Insulin Market by Application, 2019-2026, $ mn 79
Table 19. UK Human Insulin Market by Distribution Channel, 2019-2026, $ mn 79
Table 20. France Human Insulin Market by Product Type, 2019-2026, $ mn 81
Table 21. France Human Insulin Market by Application, 2019-2026, $ mn 81
Table 22. France Human Insulin Market by Distribution Channel, 2019-2026, $ mn 81
Table 23. Spain Human Insulin Market by Product Type, 2019-2026, $ mn 83
Table 24. Spain Human Insulin Market by Application, 2019-2026, $ mn 83
Table 25. Spain Human Insulin Market by Distribution Channel, 2019-2026, $ mn 83
Table 26. Italy Human Insulin Market by Product Type, 2019-2026, $ mn 85
Table 27. Italy Human Insulin Market by Application, 2019-2026, $ mn 85
Table 28. Italy Human Insulin Market by Distribution Channel, 2019-2026, $ mn 85
Table 29. Human Insulin Market in Rest of Europe by Country, 2019-2026, $ mn 87
Table 30. Europe Human Insulin Market by Key Vendor, 2019, $ mn 90
Table 31. Astra Zeneca PLC: Company Snapshot 94
Table 32. Astra Zeneca PLC: Business Segmentation 94
Table 33. Astra Zeneca PLC: Product Portfolio 95
Table 34. Astra Zeneca PLC: Revenue, 2016-2018, $ mn 95
Table 35. Astra Zeneca PLC: Recent Developments 95
Table 36. Risk Evaluation for Investing in Europe Market, 2019-2026 106
Table 37. Critical Success Factors and Key Takeaways 109